Expert Elaborates on Developments in SCLC and EGFR-Mutant NSCLC
Pharma & biotech2018-06-28
18 Views
Kathryn A. Gold, MD, discusses the evolving management of EGFR-mutant non–small cell lung cancer and the latest developments in small cell lung cancer.
Source: OncLive
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Aquestive Therapeutics (Nasdaq: AQST) Receives Complete Response Letter from FDA for Libervant (diazepam) Buccal Film for Management of Seizure Clusters
